nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylcysteine—CHUK—connective tissue—Graves' disease	0.027	0.112	CbGeAlD
Acetylcysteine—ACY1—thyroid gland—Graves' disease	0.026	0.108	CbGeAlD
Acetylcysteine—CHUK—NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10—IFIH1—Graves' disease	0.0254	0.0385	CbGpPWpGaD
Acetylcysteine—CHUK—NLR Proteins—CD40—Graves' disease	0.0246	0.0373	CbGpPWpGaD
Acetylcysteine—IKBKB—NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10—IFIH1—Graves' disease	0.023	0.0349	CbGpPWpGaD
Acetylcysteine—IKBKB—NLR Proteins—CD40—Graves' disease	0.0223	0.0338	CbGpPWpGaD
Acetylcysteine—CHUK—adipose tissue—Graves' disease	0.0207	0.0861	CbGeAlD
Acetylcysteine—GSS—eye—Graves' disease	0.0187	0.0777	CbGeAlD
Acetylcysteine—IKBKB—connective tissue—Graves' disease	0.0183	0.0763	CbGeAlD
Acetylcysteine—CHUK—thyroid gland—Graves' disease	0.0179	0.0745	CbGeAlD
Acetylcysteine—SLC7A11—adipose tissue—Graves' disease	0.017	0.0709	CbGeAlD
Acetylcysteine—SLC7A11—thyroid gland—Graves' disease	0.0148	0.0614	CbGeAlD
Acetylcysteine—CHUK—TRAF6 mediated NF-kB activation—IFIH1—Graves' disease	0.0146	0.0221	CbGpPWpGaD
Acetylcysteine—IKBKB—pituitary gland—Graves' disease	0.0141	0.0588	CbGeAlD
Acetylcysteine—IKBKB—adipose tissue—Graves' disease	0.0141	0.0585	CbGeAlD
Acetylcysteine—GSS—pituitary gland—Graves' disease	0.0139	0.0577	CbGeAlD
Acetylcysteine—GSS—adipose tissue—Graves' disease	0.0138	0.0575	CbGeAlD
Acetylcysteine—IKBKB—TRAF6 mediated NF-kB activation—IFIH1—Graves' disease	0.0132	0.02	CbGpPWpGaD
Acetylcysteine—IKBKB—thyroid gland—Graves' disease	0.0122	0.0507	CbGeAlD
Acetylcysteine—GSS—thyroid gland—Graves' disease	0.012	0.0497	CbGeAlD
Acetylcysteine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.0116	0.0175	CbGpPWpGaD
Acetylcysteine—CHUK—Apoptosis—TNFRSF25—Graves' disease	0.0099	0.015	CbGpPWpGaD
Acetylcysteine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.00949	0.0144	CbGpPWpGaD
Acetylcysteine—Drowsiness—Methimazole—Graves' disease	0.00934	0.0929	CcSEcCtD
Acetylcysteine—IKBKB—Apoptosis—TNFRSF25—Graves' disease	0.00898	0.0136	CbGpPWpGaD
Acetylcysteine—GRIN2D—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.00868	0.0132	CbGpPWpGaD
Acetylcysteine—IKBKB—Apoptosis Modulation and Signaling—TNFRSF25—Graves' disease	0.00842	0.0128	CbGpPWpGaD
Acetylcysteine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.00827	0.0126	CbGpPWpGaD
Acetylcysteine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.00807	0.0122	CbGpPWpGaD
Acetylcysteine—Drowsiness—Propylthiouracil—Graves' disease	0.00794	0.079	CcSEcCtD
Acetylcysteine—GRIN2A—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.00713	0.0108	CbGpPWpGaD
Acetylcysteine—GRIN2D—Neuronal System—GABRA3—Graves' disease	0.00665	0.0101	CbGpPWpGaD
Acetylcysteine—GRIN1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.00622	0.00944	CbGpPWpGaD
Acetylcysteine—CHUK—HIV-1 Nef: Negative effector of Fas and TNF-alpha—FASLG—Graves' disease	0.00619	0.00939	CbGpPWpGaD
Acetylcysteine—GRIN2D—Alzheimers Disease—FAS—Graves' disease	0.00613	0.00929	CbGpPWpGaD
Acetylcysteine—GRIN2B—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.00606	0.0092	CbGpPWpGaD
Acetylcysteine—CHUK—HIV-1 Nef: Negative effector of Fas and TNF-alpha—FAS—Graves' disease	0.00597	0.00905	CbGpPWpGaD
Acetylcysteine—Oedema—Methimazole—Graves' disease	0.00596	0.0593	CcSEcCtD
Acetylcysteine—CHUK—Downstream TCR signaling—HLA-DQB1—Graves' disease	0.00592	0.00899	CbGpPWpGaD
Acetylcysteine—CHUK—FAS (CD95) signaling pathway—FASLG—Graves' disease	0.0059	0.00896	CbGpPWpGaD
Acetylcysteine—CHUK—FAS (CD95) signaling pathway—FAS—Graves' disease	0.00569	0.00864	CbGpPWpGaD
Acetylcysteine—CHUK—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—IFIH1—Graves' disease	0.00556	0.00844	CbGpPWpGaD
Acetylcysteine—GRIN2A—Neuronal System—GABRA3—Graves' disease	0.00546	0.00829	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream TCR signaling—HLA-DQB1—Graves' disease	0.00537	0.00815	CbGpPWpGaD
Acetylcysteine—IKBKB—FAS (CD95) signaling pathway—FASLG—Graves' disease	0.00535	0.00812	CbGpPWpGaD
Acetylcysteine—Somnolence—Methimazole—Graves' disease	0.0053	0.0527	CcSEcCtD
Acetylcysteine—Dyspepsia—Methimazole—Graves' disease	0.00525	0.0522	CcSEcCtD
Acetylcysteine—IKBKB—FAS (CD95) signaling pathway—FAS—Graves' disease	0.00516	0.00783	CbGpPWpGaD
Acetylcysteine—Oedema—Propylthiouracil—Graves' disease	0.00507	0.0504	CcSEcCtD
Acetylcysteine—IKBKB—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—IFIH1—Graves' disease	0.00504	0.00765	CbGpPWpGaD
Acetylcysteine—GRIN2A—Alzheimers Disease—FAS—Graves' disease	0.00503	0.00763	CbGpPWpGaD
Acetylcysteine—GRIN1—Neuronal System—GABRA3—Graves' disease	0.00477	0.00723	CbGpPWpGaD
Acetylcysteine—Urticaria—Methimazole—Graves' disease	0.00473	0.0471	CcSEcCtD
Acetylcysteine—Body temperature increased—Methimazole—Graves' disease	0.00471	0.0469	CcSEcCtD
Acetylcysteine—GRIN2B—Neuronal System—GABRA3—Graves' disease	0.00465	0.00705	CbGpPWpGaD
Acetylcysteine—CHUK—FoxO family signaling—FASLG—Graves' disease	0.00451	0.00684	CbGpPWpGaD
Acetylcysteine—CHUK—TCR signaling in naïve CD8+ T cells—CD8A—Graves' disease	0.00451	0.00684	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream TCR signaling—HLA-DRB1—Graves' disease	0.00451	0.00683	CbGpPWpGaD
Acetylcysteine—Somnolence—Propylthiouracil—Graves' disease	0.0045	0.0448	CcSEcCtD
Acetylcysteine—Dyspepsia—Propylthiouracil—Graves' disease	0.00446	0.0444	CcSEcCtD
Acetylcysteine—CHUK—TCR signaling—HLA-DQB1—Graves' disease	0.00443	0.00672	CbGpPWpGaD
Acetylcysteine—GRIN1—Alzheimers Disease—FAS—Graves' disease	0.00439	0.00666	CbGpPWpGaD
Acetylcysteine—GRIN2B—Alzheimers Disease—FAS—Graves' disease	0.00428	0.00649	CbGpPWpGaD
Acetylcysteine—Pruritus—Methimazole—Graves' disease	0.00422	0.0419	CcSEcCtD
Acetylcysteine—ACY1—Metabolism—GC—Graves' disease	0.00419	0.00636	CbGpPWpGaD
Acetylcysteine—GRIN1—Spinal Cord Injury—CXCL10—Graves' disease	0.00414	0.00628	CbGpPWpGaD
Acetylcysteine—IKBKB—FoxO family signaling—FASLG—Graves' disease	0.00409	0.0062	CbGpPWpGaD
Acetylcysteine—CHUK—Interleukin-11 Signaling Pathway—ICAM1—Graves' disease	0.00409	0.0062	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR signaling in naïve CD8+ T cells—CD8A—Graves' disease	0.00409	0.0062	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream TCR signaling—HLA-DRB1—Graves' disease	0.00409	0.0062	CbGpPWpGaD
Acetylcysteine—Urticaria—Propylthiouracil—Graves' disease	0.00403	0.04	CcSEcCtD
Acetylcysteine—CHUK—Validated transcriptional targets of TAp63 isoforms—FAS—Graves' disease	0.00402	0.0061	CbGpPWpGaD
Acetylcysteine—CHUK—TCR signaling in naïve CD8+ T cells—HLA-A—Graves' disease	0.00402	0.00609	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR signaling—HLA-DQB1—Graves' disease	0.00402	0.00609	CbGpPWpGaD
Acetylcysteine—Body temperature increased—Propylthiouracil—Graves' disease	0.00401	0.0398	CcSEcCtD
Acetylcysteine—Vomiting—Methimazole—Graves' disease	0.00379	0.0377	CcSEcCtD
Acetylcysteine—Rash—Methimazole—Graves' disease	0.00376	0.0374	CcSEcCtD
Acetylcysteine—Dermatitis—Methimazole—Graves' disease	0.00375	0.0373	CcSEcCtD
Acetylcysteine—SLC7A11—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00372	0.00564	CbGpPWpGaD
Acetylcysteine—IKBKB—Interleukin-11 Signaling Pathway—ICAM1—Graves' disease	0.00371	0.00562	CbGpPWpGaD
Acetylcysteine—IKBKB—Validated transcriptional targets of TAp63 isoforms—FAS—Graves' disease	0.00365	0.00554	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR signaling in naïve CD8+ T cells—HLA-A—Graves' disease	0.00364	0.00552	CbGpPWpGaD
Acetylcysteine—Pruritus—Propylthiouracil—Graves' disease	0.00358	0.0357	CcSEcCtD
Acetylcysteine—GRIN2D—Alzheimers Disease—IL1B—Graves' disease	0.00358	0.00544	CbGpPWpGaD
Acetylcysteine—Nausea—Methimazole—Graves' disease	0.00354	0.0352	CcSEcCtD
Acetylcysteine—CHUK—Toll-like Receptor Signaling Pathway—CD40—Graves' disease	0.00352	0.00534	CbGpPWpGaD
Acetylcysteine—CHUK—RANKL/RANK Signaling Pathway—ICAM1—Graves' disease	0.00342	0.00519	CbGpPWpGaD
Acetylcysteine—CHUK—IL1-mediated signaling events—IL1B—Graves' disease	0.00341	0.00517	CbGpPWpGaD
Acetylcysteine—CHUK—EBV LMP1 signaling—TNF—Graves' disease	0.00338	0.00513	CbGpPWpGaD
Acetylcysteine—CHUK—Canonical NF-kappaB pathway—TNF—Graves' disease	0.00338	0.00513	CbGpPWpGaD
Acetylcysteine—CHUK—TCR signaling—HLA-DRB1—Graves' disease	0.00337	0.00511	CbGpPWpGaD
Acetylcysteine—Vomiting—Propylthiouracil—Graves' disease	0.00322	0.032	CcSEcCtD
Acetylcysteine—Rash—Propylthiouracil—Graves' disease	0.00319	0.0318	CcSEcCtD
Acetylcysteine—IKBKB—Toll-like Receptor Signaling Pathway—CD40—Graves' disease	0.00319	0.00484	CbGpPWpGaD
Acetylcysteine—Dermatitis—Propylthiouracil—Graves' disease	0.00319	0.0317	CcSEcCtD
Acetylcysteine—CHUK—Downstream TCR signaling—CD4—Graves' disease	0.00318	0.00482	CbGpPWpGaD
Acetylcysteine—IKBKB—Type II diabetes mellitus—TNF—Graves' disease	0.00318	0.00482	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—B3GNT2—Graves' disease	0.00318	0.00482	CbGpPWpGaD
Acetylcysteine—CHUK—Toll-like Receptor Signaling Pathway—CXCL10—Graves' disease	0.00315	0.00477	CbGpPWpGaD
Acetylcysteine—IKBKB—RANKL/RANK Signaling Pathway—ICAM1—Graves' disease	0.0031	0.0047	CbGpPWpGaD
Acetylcysteine—IKBKB—IL1-mediated signaling events—IL1B—Graves' disease	0.00309	0.00469	CbGpPWpGaD
Acetylcysteine—CHUK—TCR signaling in naïve CD4+ T cells—HLA-DRB1—Graves' disease	0.00308	0.00467	CbGpPWpGaD
Acetylcysteine—IKBKB—EBV LMP1 signaling—TNF—Graves' disease	0.00307	0.00465	CbGpPWpGaD
Acetylcysteine—IKBKB—Canonical NF-kappaB pathway—TNF—Graves' disease	0.00307	0.00465	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR signaling—HLA-DRB1—Graves' disease	0.00305	0.00463	CbGpPWpGaD
Acetylcysteine—Nausea—Propylthiouracil—Graves' disease	0.00301	0.0299	CcSEcCtD
Acetylcysteine—CHUK—Interleukin-1 signaling—IL1B—Graves' disease	0.00299	0.00454	CbGpPWpGaD
Acetylcysteine—CHUK—TCR Signaling Pathway—CD8A—Graves' disease	0.00295	0.00447	CbGpPWpGaD
Acetylcysteine—GRIN2A—Alzheimers Disease—IL1B—Graves' disease	0.00294	0.00447	CbGpPWpGaD
Acetylcysteine—CHUK—NOD pathway—IL1B—Graves' disease	0.00293	0.00445	CbGpPWpGaD
Acetylcysteine—CHUK—Apoptosis—FASLG—Graves' disease	0.00293	0.00445	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream TCR signaling—CD4—Graves' disease	0.00288	0.00437	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll-like Receptor Signaling Pathway—CXCL10—Graves' disease	0.00285	0.00433	CbGpPWpGaD
Acetylcysteine—CHUK—Apoptosis—FAS—Graves' disease	0.00283	0.00429	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR signaling in naïve CD4+ T cells—HLA-DRB1—Graves' disease	0.00279	0.00423	CbGpPWpGaD
Acetylcysteine—CHUK—Regulation of toll-like receptor signaling pathway—CD40—Graves' disease	0.00275	0.00417	CbGpPWpGaD
Acetylcysteine—GRIN1—Spinal Cord Injury—ICAM1—Graves' disease	0.00274	0.00416	CbGpPWpGaD
Acetylcysteine—IKBKB—Interleukin-1 signaling—IL1B—Graves' disease	0.00271	0.00412	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR Signaling Pathway—CD8A—Graves' disease	0.00267	0.00406	CbGpPWpGaD
Acetylcysteine—CHUK—TCR Signaling Pathway—FAS—Graves' disease	0.00267	0.00406	CbGpPWpGaD
Acetylcysteine—IKBKB—NOD pathway—IL1B—Graves' disease	0.00266	0.00404	CbGpPWpGaD
Acetylcysteine—IKBKB—Apoptosis—FASLG—Graves' disease	0.00266	0.00403	CbGpPWpGaD
Acetylcysteine—GRIN2D—Alzheimers Disease—TNF—Graves' disease	0.0026	0.00395	CbGpPWpGaD
Acetylcysteine—GRIN1—Alzheimers Disease—IL1B—Graves' disease	0.00257	0.0039	CbGpPWpGaD
Acetylcysteine—IKBKB—Apoptosis—FAS—Graves' disease	0.00256	0.00389	CbGpPWpGaD
Acetylcysteine—CHUK—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—Graves' disease	0.00253	0.00384	CbGpPWpGaD
Acetylcysteine—GRIN2B—Alzheimers Disease—IL1B—Graves' disease	0.0025	0.0038	CbGpPWpGaD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—CD40—Graves' disease	0.00249	0.00378	CbGpPWpGaD
Acetylcysteine—IKBKB—Apoptosis Modulation and Signaling—FASLG—Graves' disease	0.00249	0.00378	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—HLA-E—Graves' disease	0.00246	0.00374	CbGpPWpGaD
Acetylcysteine—CHUK—Regulation of toll-like receptor signaling pathway—CXCL10—Graves' disease	0.00246	0.00373	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR Signaling Pathway—FAS—Graves' disease	0.00242	0.00368	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—GC—Graves' disease	0.00241	0.00365	CbGpPWpGaD
Acetylcysteine—IKBKB—Apoptosis Modulation and Signaling—FAS—Graves' disease	0.0024	0.00365	CbGpPWpGaD
Acetylcysteine—CHUK—TCR signaling—CD4—Graves' disease	0.00237	0.0036	CbGpPWpGaD
Acetylcysteine—CHUK—IL-1 signaling pathway—IL1B—Graves' disease	0.00232	0.00352	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—HLA-E—Graves' disease	0.00232	0.00352	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by Interleukins—IL2RA—Graves' disease	0.0023	0.00349	CbGpPWpGaD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—CXCL10—Graves' disease	0.00223	0.00338	CbGpPWpGaD
Acetylcysteine—CHUK—TCR signaling in naïve CD4+ T cells—CD4—Graves' disease	0.00217	0.00329	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR signaling—CD4—Graves' disease	0.00215	0.00327	CbGpPWpGaD
Acetylcysteine—GRIN2A—Alzheimers Disease—TNF—Graves' disease	0.00214	0.00324	CbGpPWpGaD
Acetylcysteine—IKBKB—IL-1 signaling pathway—IL1B—Graves' disease	0.0021	0.00319	CbGpPWpGaD
Acetylcysteine—CHUK—TWEAK Signaling Pathway—TNF—Graves' disease	0.00209	0.00317	CbGpPWpGaD
Acetylcysteine—GRIN1—Spinal Cord Injury—IFNG—Graves' disease	0.00209	0.00317	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by Interleukins—IL2RA—Graves' disease	0.00208	0.00316	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR signaling in naïve CD4+ T cells—CD4—Graves' disease	0.00197	0.00299	CbGpPWpGaD
Acetylcysteine—CHUK—TNF receptor signaling pathway —TNF—Graves' disease	0.00194	0.00295	CbGpPWpGaD
Acetylcysteine—IKBKB—TWEAK Signaling Pathway—TNF—Graves' disease	0.00189	0.00287	CbGpPWpGaD
Acetylcysteine—GRIN1—Alzheimers Disease—TNF—Graves' disease	0.00186	0.00283	CbGpPWpGaD
Acetylcysteine—GRIN1—Spinal Cord Injury—IL1B—Graves' disease	0.00186	0.00283	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—B3GNT2—Graves' disease	0.00182	0.00277	CbGpPWpGaD
Acetylcysteine—GRIN2B—Alzheimers Disease—TNF—Graves' disease	0.00182	0.00276	CbGpPWpGaD
Acetylcysteine—CHUK—Leptin signaling pathway—IL1B—Graves' disease	0.00181	0.00275	CbGpPWpGaD
Acetylcysteine—IKBKB—TNF receptor signaling pathway —TNF—Graves' disease	0.00176	0.00267	CbGpPWpGaD
Acetylcysteine—CHUK—TCR Signaling Pathway—CD4—Graves' disease	0.00169	0.00257	CbGpPWpGaD
Acetylcysteine—CHUK—Cardiac Hypertrophic Response—TNF—Graves' disease	0.00168	0.00255	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—HLA-B—Graves' disease	0.00165	0.00251	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.00164	0.0025	CbGpPWpGaD
Acetylcysteine—IKBKB—Leptin signaling pathway—IL1B—Graves' disease	0.00164	0.00249	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—HLA-E—Graves' disease	0.00161	0.00244	CbGpPWpGaD
Acetylcysteine—SLC22A6—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.0016	0.00242	CbGpPWpGaD
Acetylcysteine—CHUK—TCR Signaling Pathway—IL1B—Graves' disease	0.00156	0.00237	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR Signaling Pathway—CD4—Graves' disease	0.00154	0.00233	CbGpPWpGaD
Acetylcysteine—IKBKB—Cardiac Hypertrophic Response—TNF—Graves' disease	0.00153	0.00232	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—FASLG—Graves' disease	0.00153	0.00232	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.00152	0.0023	CbGpPWpGaD
Acetylcysteine—GRIN1—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.00149	0.00226	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—FAS—Graves' disease	0.00147	0.00223	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.00146	0.00222	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—HLA-E—Graves' disease	0.00146	0.00221	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00145	0.00221	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—IL2RA—Graves' disease	0.00143	0.00217	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR Signaling Pathway—IL1B—Graves' disease	0.00142	0.00215	CbGpPWpGaD
Acetylcysteine—CHUK—Toll-like Receptor Signaling Pathway—IL1B—Graves' disease	0.00142	0.00215	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by Interleukins—IL1B—Graves' disease	0.00135	0.00205	CbGpPWpGaD
Acetylcysteine—GRIN1—Spinal Cord Injury—TNF—Graves' disease	0.00135	0.00205	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll-like Receptor Signaling Pathway—IL1B—Graves' disease	0.00128	0.00195	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—HLA-DQB1—Graves' disease	0.00127	0.00193	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by Interleukins—IL1B—Graves' disease	0.00123	0.00186	CbGpPWpGaD
Acetylcysteine—CHUK—MicroRNAs in cardiomyocyte hypertrophy—TNF—Graves' disease	0.0012	0.00182	CbGpPWpGaD
Acetylcysteine—CHUK—Apoptosis—TNF—Graves' disease	0.0012	0.00182	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—HLA-DQB1—Graves' disease	0.00116	0.00175	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—IFIH1—Graves' disease	0.00114	0.00174	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—HLA-B—Graves' disease	0.00114	0.00174	CbGpPWpGaD
Acetylcysteine—CHUK—TNF alpha Signaling Pathway—TNF—Graves' disease	0.00112	0.00169	CbGpPWpGaD
Acetylcysteine—CHUK—Regulation of toll-like receptor signaling pathway—IL1B—Graves' disease	0.00111	0.00168	CbGpPWpGaD
Acetylcysteine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—Graves' disease	0.00109	0.00165	CbGpPWpGaD
Acetylcysteine—IKBKB—Apoptosis—TNF—Graves' disease	0.00109	0.00165	CbGpPWpGaD
Acetylcysteine—GRIN1—SIDS Susceptibility Pathways—TNF—Graves' disease	0.00108	0.00164	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—IL2RA—Graves' disease	0.00107	0.00163	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—HLA-A—Graves' disease	0.00106	0.00161	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—IFIH1—Graves' disease	0.00104	0.00157	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—HLA-B—Graves' disease	0.00104	0.00157	CbGpPWpGaD
Acetylcysteine—CHUK—Toll-like Receptor Signaling Pathway—TNF—Graves' disease	0.00103	0.00156	CbGpPWpGaD
Acetylcysteine—IKBKB—TNF alpha Signaling Pathway—TNF—Graves' disease	0.00101	0.00153	CbGpPWpGaD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—IL1B—Graves' disease	0.001	0.00152	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IL2RA—Graves' disease	0.000972	0.00148	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—HLA-DRB1—Graves' disease	0.000969	0.00147	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—HLA-A—Graves' disease	0.000962	0.00146	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll-like Receptor Signaling Pathway—TNF—Graves' disease	0.000931	0.00141	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—ICAM1—Graves' disease	0.00093	0.00141	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—HLA-E—Graves' disease	0.000901	0.00137	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—HLA-DRB1—Graves' disease	0.000878	0.00133	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—HLA-E—Graves' disease	0.000865	0.00131	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—IL1B—Graves' disease	0.000861	0.00131	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CD40—Graves' disease	0.000845	0.00128	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—ICAM1—Graves' disease	0.000843	0.00128	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CTLA4—Graves' disease	0.000833	0.00126	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—HLA-E—Graves' disease	0.000817	0.00124	CbGpPWpGaD
Acetylcysteine—CHUK—Regulation of toll-like receptor signaling pathway—TNF—Graves' disease	0.000802	0.00122	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—B3GNT2—Graves' disease	0.00079	0.0012	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—HLA-E—Graves' disease	0.000784	0.00119	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CD40—Graves' disease	0.000767	0.00116	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CTLA4—Graves' disease	0.000755	0.00115	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GC—Graves' disease	0.000732	0.00111	CbGpPWpGaD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—Graves' disease	0.000727	0.0011	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—IFNG—Graves' disease	0.000707	0.00107	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—HLA-DQB1—Graves' disease	0.000686	0.00104	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IFIH1—Graves' disease	0.000667	0.00101	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—HLA-B—Graves' disease	0.000642	0.000974	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IFNG—Graves' disease	0.000642	0.000973	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CD8A—Graves' disease	0.000641	0.000972	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—IL1B—Graves' disease	0.000631	0.000957	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—TNF—Graves' disease	0.000625	0.000948	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—HLA-DQB1—Graves' disease	0.000622	0.000944	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	0.000622	0.000943	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—HLA-B—Graves' disease	0.000616	0.000935	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IFIH1—Graves' disease	0.000605	0.000917	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—HLA-B—Graves' disease	0.000582	0.000883	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CD8A—Graves' disease	0.000581	0.000881	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IL1B—Graves' disease	0.000572	0.000868	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—HLA-A—Graves' disease	0.000571	0.000866	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—HLA-B—Graves' disease	0.000559	0.000848	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—B3GNT2—Graves' disease	0.000555	0.000842	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HLA-E—Graves' disease	0.000525	0.000796	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000522	0.000791	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—HLA-A—Graves' disease	0.000518	0.000786	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CD40—Graves' disease	0.000513	0.000778	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CTLA4—Graves' disease	0.000505	0.000767	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—ICAM1—Graves' disease	0.000501	0.00076	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HLA-E—Graves' disease	0.000476	0.000722	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—HLA-DRB1—Graves' disease	0.000473	0.000718	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CD40—Graves' disease	0.000465	0.000705	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TSHR—Graves' disease	0.000459	0.000696	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CTLA4—Graves' disease	0.000458	0.000695	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—ICAM1—Graves' disease	0.000454	0.000689	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—TNF—Graves' disease	0.00043	0.000652	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—TNF—Graves' disease	0.000419	0.000636	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HLA-DQB1—Graves' disease	0.000416	0.000631	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TSHR—Graves' disease	0.000416	0.000631	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CD8A—Graves' disease	0.000389	0.00059	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CD4—Graves' disease	0.000383	0.000581	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HLA-DQB1—Graves' disease	0.000377	0.000572	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HLA-B—Graves' disease	0.000374	0.000567	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CD4—Graves' disease	0.000368	0.000558	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CD8A—Graves' disease	0.000352	0.000535	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL2RA—Graves' disease	0.00035	0.000531	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CD4—Graves' disease	0.000347	0.000527	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HLA-A—Graves' disease	0.000346	0.000525	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HLA-B—Graves' disease	0.000339	0.000514	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CD4—Graves' disease	0.000334	0.000506	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—HLA-A—Graves' disease	0.00032	0.000485	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL2RA—Graves' disease	0.000318	0.000482	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HLA-DRB1—Graves' disease	0.000316	0.00048	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HLA-A—Graves' disease	0.000314	0.000476	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—ICAM1—Graves' disease	0.000304	0.000461	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CXCL10—Graves' disease	0.000296	0.00045	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HLA-DRB1—Graves' disease	0.000287	0.000435	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—ICAM1—Graves' disease	0.000275	0.000418	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CXCL10—Graves' disease	0.000269	0.000408	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IFNG—Graves' disease	0.000231	0.000351	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IL2RA—Graves' disease	0.000226	0.000344	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CD4—Graves' disease	0.000223	0.000339	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IFNG—Graves' disease	0.00021	0.000318	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL1B—Graves' disease	0.000206	0.000313	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CD4—Graves' disease	0.000206	0.000313	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IL2RA—Graves' disease	0.000205	0.000312	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CD4—Graves' disease	0.000202	0.000307	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL1B—Graves' disease	0.000187	0.000284	CbGpPWpGaD
